Chorale Director to Give First Performance After Heart Transplant

Classic Arts News   Chorale Director to Give First Performance After Heart Transplant
 
Collegiate Chorale director Robert Bass will conduct Carl Orff's Carmina Burana tonight at the Verbier Festival in Switzerland, in his first concert since receiving a new heart four months ago.

The 53-year-old director has been suffering from a type of amyloidosis, a group of rare diseases characterized by a buildup of abnormal protein deposits in one or more organs. Bass's kind, primary amyloidosis, is the most common and originates in the bone marrow, which controls the production and recycling of antibodies. Under 2,000 new cases are reported annually.

Primary amyloidosis inhibits the breakdown of antibodies, leading to protein accumulation in the blood and deposit in organs and tissues. Because the disease shares its symptoms with several others, Bass was initially diagnosed in January with heart failure after months of day-to-day fatigue and shortness of breath.

Another doctor realized it could be amyloidosis and so directed him to the New York Presbyterian Hospital Transplant Institute. There Bass was diagnosed with the disorder and given the go-ahead for a heart transplant, waiting less than two months for a heart from a teen matching his body size and rare blood type.

Despite complications, the disease has not spread and the new organ has not been rejected.

"Having a new heart has changed everything," Bass told The New York Times. "I've just begun rehearsing again, and all of the sensations, whether they be as a musician or as a person — everything is different."

Bass will finish his medical treatment with chemotherapy and a stem-cell transplant next month in a clinical trial at Memorial Sloan Kettering Cancer Center. Once fatal in over 95% of patients, amyloidosis saw a breakthrough in 1994 with stem-cell ransplants, which along with chemotherapy is its most aggressive course of treatment.

After being cured, he intends on organizing Collegiate Chorale concerts to broaden public understanding of the disease.

"I would like people to know that you can kick it," said Bass. "It's just not necessary that anyone be misdiagnosed anymore."

Today’s Most Popular News:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!